SCN7A
Sodium channel protein type 7 subunit alpha
Also known as: NaG, Nav2.1, Nav2.2, SCN6A, SCN7A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01118
- Gene
- SCN7A
- Ensembl
- ENSG00000136546
- Chromosome
- 2
- Canonical length
- 1682 aa
- Protein class
- FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes one of the many voltage-gated sodium channel proteins. For proper functioning of neurons and muscles during action potentials, voltage-gated sodium channels direct sodium ion diffusion for membrane depolarization. This sodium channel protein has some atypical characteristics; the similarity between the human and mouse proteins is lower compared to other orthologous sodium channel pairs. Also, the S4 segments, which sense voltage changes, have fewer positive charged residues that in other sodium channels; domain 4 has fewer arginine and lysine residues compared to other sodium channel proteins. Several alternatively spliced transcript variants exist, but the full-length natures of all of them remain unknown. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
1682 residues, UniProt reviewed canonical sequence.
>Q01118|SCN7A
1 MLASPEPKGL VPFTKESFEL IKQHIAKTHN EDHEEEDLKP TPDLEVGKKL PFIYGNLSQG
61 MVSEPLEDVD PYYYKKKNTF IVLNKNRTIF RFNAASILCT LSPFNCIRRT TIKVLVHPFF
121 QLFILISVLI DCVFMSLTNL PKWRPVLENT LLGIYTFEIL VKLFARGVWA GSFSFLGDPW
181 NWLDFSVTVF EVIIRYSPLD FIPTLQTART LRILKIIPLN QGLKSLVGVL IHCLKQLIGV
241 IILTLFFLSI FSLIGMGLFM GNLKHKCFRW PQENENETLH NRTGNPYYIR ETENFYYLEG
301 ERYALLCGNR TDAGQCPEGY VCVKAGINPD QGFTNFDSFG WALFALFRLM AQDYPEVLYH
361 QILYASGKVY MIFFVVVSFL FSFYMASLFL GILAMAYEEE KQRVGEISKK IEPKFQQTGK
421 ELQEGNETDE AKTIQIEMKK RSPISTDTSL DVLEDATLRH KEELEKSKKI CPLYWYKFAK
481 TFLIWNCSPC WLKLKEFVHR IIMAPFTDLF LIICIILNVC FLTLEHYPMS KQTNTLLNIG
541 NLVFIGIFTA EMIFKIIAMH PYGYFQVGWN IFDSMIVFHG LIELCLANVA GMALLRLFRM
601 LRIFKLGKYW PTFQILMWSL SNSWVALKDL VLLLFTFIFF SAAFGMKLFG KNYEEFVCHI
661 DKDCQLPRWH MHDFFHSFLN VFRILCGEWV ETLWDCMEVA GQSWCIPFYL MVILIGNLLV
721 LYLFLALVSS FSSCKDVTAE ENNEAKNLQL AVARIKKGIN YVLLKILCKT QNVPKDTMDH
781 VNEVYVKEDI SDHTLSELSN TQDFLKDKEK SSGTEKNATE NESQSLIPSP SVSETVPIAS
841 GESDIENLDN KEIQSKSGDG GSKEKIKQSS SSECSTVDIA ISEEEEMFYG GERSKHLKNG
901 CRRGSSLGQI SGASKKGKIW QNIRKTCCKI VENNWFKCFI GLVTLLSTGT LAFEDIYMDQ
961 RKTIKILLEY ADMIFTYIFI LEMLLKWMAY GFKAYFSNGW YRLDFVVVIV FCLSLIGKTR
1021 EELKPLISMK FLRPLRVLSQ FERMKVVVRA LIKTTLPTLN VFLVCLMIWL IFSIMGVDLF
1081 AGRFYECIDP TSGERFPSSE VMNKSRCESL LFNESMLWEN AKMNFDNVGN GFLSLLQVAT
1141 FNGWITIMNS AIDSVAVNIQ PHFEVNIYMY CYFINFIIFG VFLPLSMLIT VIIDNFNKHK
1201 IKLGGSNIFI TVKQRKQYRR LKKLMYEDSQ RPVPRPLNKL QGFIFDVVTS QAFNVIVMVL
1261 ICFQAIAMMI DTDVQSLQMS IALYWINSIF VMLYTMECIL KLIAFRCFYF TIAWNIFDFM
1321 VVIFSITGLC LPMTVGSYLV PPSLVQLILL SRIIHMLRLG KGPKVFHNLM LPLMLSLPAL
1381 LNIILLIFLV MFIYAVFGMY NFAYVKKEAG INDVSNFETF GNSMLCLFQV AIFAGWDGML
1441 DAIFNSKWSD CDPDKINPGT QVRGDCGNPS VGIFYFVSYI LISWLIIVNM YIVVVMEFLN
1501 IASKKKNKTL SEDDFRKFFQ VWKRFDPDRT QYIDSSKLSD FAAALDPPLF MAKPNKGQLI
1561 ALDLPMAVGD RIHCLDILLA FTKRVMGQDV RMEKVVSEIE SGFLLANPFK ITCEPITTTL
1621 KRKQEAVSAT IIQRAYKNYR LRRNDKNTSD IHMIDGDRDV HATKEGAYFD KAKEKSPIQS
1681 QILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCN7A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 24
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- ovary: 37 nTPM
- colon: 33 nTPM
- lung: 26 nTPM
- heart muscle: 20 nTPM
- tongue: 14 nTPM
- placenta: 11 nTPM
Single-cell type
- schwann cells: 1,625 nCPM
- peritubular myoid cells: 369 nCPM
- leydig cells: 316 nCPM
- fibro-adipogenic progenitors: 269 nCPM
- hepatic stellate cells: 142 nCPM
- ovarian stromal cells: 117 nCPM
Immune cell
- basophil: 0.8 nTPM
- total PBMC: 0.5 nTPM
- neutrophil: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- hypothalamus: 27 nTPM
- midbrain: 23 nTPM
- pons: 19 nTPM
- medulla oblongata: 16 nTPM
- basal ganglia: 15 nTPM
- thalamus: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle cell action potential involved in contraction
- cellular homeostasis
- osmosensory signaling pathway
- response to bacterium
- sodium ion homeostasis
- sodium ion transmembrane transport
Molecular functions
- osmolarity-sensing monoatomic cation channel activity
- sodium channel activity
- transmembrane transporter binding
- voltage-gated sodium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Voltage gated sodium channel, alpha subunit
- Ion transport domain
- Sodium ion transport-associated domain
- Voltage-dependent channel domain superfamily
- Voltage-gated cation channel calcium and sodium
- Voltage-gated sodium channel alpha subunit, inactivation gate
- SCN5A-like, C-terminal IQ motif
- Ion transport protein
- Sodium ion transport-associated
- SCN5A-like, C-terminal IQ motif
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SCN7A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCN7A as an antibody target. Whether an autoantibody or antibody against SCN7A could matter depends on whether native SCN7A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCN7A is annotated at the cell surface, where native SCN7A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SCN7A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...